Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Ardelyx Inc (NASDAQ: ARDX) closed at $5.6 in the last session, up 3.70% from day before closing price of $5.4. In other words, the price has increased by $3.70 from its previous closing price. On the day, 3.31 million shares were traded. ARDX stock price reached its highest trading level at $5.64 during the session, while it also had its lowest trading level at $5.43.
Ratios:
We take a closer look at ARDX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.03 and its Current Ratio is at 4.30. In the meantime, Its Debt-to-Equity ratio is 1.48 whereas as Long-Term Debt/Eq ratio is at 1.47.
On May 02, 2025, Raymond James Downgraded its rating to Outperform which previously was Strong Buy but kept the price unchanged to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 16 ’25 when MOTT DAVID M bought 200,000 shares for $3.63 per share. The transaction valued at 725,880 led to the insider holds 2,896,871 shares of the business.
MOTT DAVID M bought 200,000 shares of ARDX for $737,260 on Jun 09 ’25. The Director now owns 2,696,871 shares after completing the transaction at $3.69 per share. On May 20 ’25, another insider, Williams Laura A, who serves as the Chief Medical Officer of the company, sold 6,421 shares for $4.08 each. As a result, the insider received 26,207 and left with 402,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1349504768 and an Enterprise Value of 1345455872. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.49 while its Price-to-Book (P/B) ratio in mrq is 9.66. Its current Enterprise Value per Revenue stands at 3.484 whereas that against EBITDA is -35.319.
Stock Price History:
The Beta on a monthly basis for ARDX is 0.72, which has changed by -0.014084518 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, ARDX has reached a high of $7.18, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is 32.76%, while the 200-Day Moving Average is calculated to be 15.46%.
Shares Statistics:
According to the various share statistics, ARDX traded on average about 4.65M shares per day over the past 3-months and 5492610 shares per day over the past 10 days. A total of 240.77M shares are outstanding, with a floating share count of 232.02M. Insiders hold about 3.72% of the company’s shares, while institutions hold 70.55% stake in the company. Shares short for ARDX as of 1753920000 were 26241983 with a Short Ratio of 5.65, compared to 1751241600 on 27723305. Therefore, it implies a Short% of Shares Outstanding of 26241983 and a Short% of Float of 12.33.
Earnings Estimates
As of right now, 6.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.04, with high estimates of $0.04 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.22 and -$0.43 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is $0.04, with 6.0 analysts recommending between $0.32 and -$0.2.
Revenue Estimates
According to 12 analysts, the current quarter’s revenue is expected to be $100.73M. It ranges from a high estimate of $109.86M to a low estimate of $94.6M. As of the current estimate, Ardelyx Inc’s year-ago sales were $98.24MFor the next quarter, 12 analysts are estimating revenue of $112.75M. There is a high estimate of $127.28M for the next quarter, whereas the lowest estimate is $100.2M.
A total of 12 analysts have provided revenue estimates for ARDX’s current fiscal year. The highest revenue estimate was $408.92M, while the lowest revenue estimate was $366.5M, resulting in an average revenue estimate of $385.24M. In the same quarter a year ago, actual revenue was $333.62MBased on 12 analysts’ estimates, the company’s revenue will be $492.41M in the next fiscal year. The high estimate is $559.73M and the low estimate is $394.03M.
